Interpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpoint

被引:94
|
作者
Duffull, Stephen B. [1 ]
Wright, Daniel F. B. [1 ]
Winter, Helen R. [1 ,2 ]
机构
[1] Univ Otago, Sch Pharm, Dunedin 9054, New Zealand
[2] Global Alliance TB Drug Dev, New York, NY 10005 USA
关键词
pharmacodynamics; pharmacokinetics; pharmacometrics; population analyses; statistical models; CYSTIC-FIBROSIS PATIENTS; DRUG DEVELOPMENT; DOSING STRATEGY; RENAL-FUNCTION; MODEL; ENOXAPARIN; PARAMETERS; DESIGN; ITRACONAZOLE; SIMULATION;
D O I
10.1111/j.1365-2125.2010.03891.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The population analysis approach is an important tool for clinical pharmacology in aiding the dose individualization of medicines. However, due to their statistical complexity the clinical utility of population analyses is often overlooked. One of the key reasons to conduct a population analysis is to investigate the potential benefits of individualization of drug dosing based on patient characteristics (termed covariate identification). The purpose of this review is to provide a tool to interpret and extract information from publications that describe population analysis. The target audience is those readers who are aware of population analyses but have not conducted the technical aspects of an analysis themselves. Initially we introduce the general framework of population analysis and work through a simple example with visual plots. We then follow-up with specific details on how to interpret population analyses for the purpose of identifying covariates and how to interpret their likely importance for dose individualization.
引用
收藏
页码:807 / 814
页数:8
相关论文
共 50 条
  • [1] Guidelines for the Quality Control of Population Pharmacokinetic-Pharmacodynamic Analyses: an Industry Perspective
    Bonate, P. L.
    Strougo, A.
    Desai, A.
    Roy, M.
    Yassen, A.
    van der Walt, J. S.
    Kaibara, A.
    Tannenbaum, S.
    AAPS JOURNAL, 2012, 14 (04): : 749 - 758
  • [2] A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
    Ari Brekkan
    Luis Lopez-Lazaro
    Gunnar Yngman
    Elodie L. Plan
    Chayan Acharya
    Andrew C. Hooker
    Suresh Kankanwadi
    Mats O. Karlsson
    The AAPS Journal, 20
  • [3] Population pharmacokinetic-pharmacodynamic analysis of givinostat
    Fiorentini, Francesco
    Germani, Massimiliano
    Del Bene, Francesca
    Pellizzoni, Cinzia
    Cazzaniga, Sara
    Rocchetti, Maurizio
    Bettica, Paolo
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2023, 19 (04) : 229 - 238
  • [4] A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
    Brekkan, Ari
    Lopez-Lazaro, Luis
    Yngman, Gunnar
    Plan, Elodie L.
    Acharya, Chayan
    Hooker, Andrew C.
    Kankanwadi, Suresh
    Karlsson, Mats O.
    AAPS JOURNAL, 2018, 20 (05):
  • [5] Clinical pharmacokinetic-pharmacodynamic analyses: a critical element for developing antibacterial agents
    Bhavnani, Sujata M.
    Hammel, Jeffrey P.
    CURRENT OPINION IN PHARMACOLOGY, 2017, 36 : 124 - 129
  • [6] Deterministic identifiability of population pharmacokinetic and pharmacokinetic-pharmacodynamic models
    Siripuram, Vijay K.
    Wright, Daniel F. B.
    Barclay, Murray L.
    Duffull, Stephen B.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 (05) : 415 - 423
  • [7] Population pharmacokinetic-pharmacodynamic modelling in oncology: a tool for predicting clinical response
    Bender, Brendan C.
    Schindler, Emilie
    Friberg, Lena E.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 79 (01) : 56 - 71
  • [8] Pharmacokinetic-pharmacodynamic population modelling in paediatric anaesthesia and its clinical translation
    Morse, James D.
    Hannam, Jacqueline
    Anderson, Brian J.
    CURRENT OPINION IN ANESTHESIOLOGY, 2019, 32 (03) : 353 - 362
  • [9] Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients
    Mentré, F
    Pousset, F
    Comets, E
    Plaud, B
    Diquet, B
    Montalescot, G
    Ankri, A
    Mallet, A
    Lechat, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (01) : 64 - 78
  • [10] Population Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationships for Docetaxel
    René Bruno
    Nicole Vivier
    Christine Veyrat-Follet
    Guy Montay
    Gerald R. Rhodes
    Investigational New Drugs, 2001, 19 : 163 - 169